Recombinant Rat IL2RA Protein (Met1-Gln235), His-tagged
Cat.No. : | IL2RA-942R |
Product Overview : | Recombinant Rat IL2RA Protein (NP_037295.1) (Met1-Gln235) was produced by Baculovirus-Insect Cells expression system. This protein was expressed with a polyhistidine tag at the C-terminus. |
- Specification
- Gene Information
- Related Products
Description : | CD25 (alpha-chain of IL-2 receptor, or IL2RA), is a type I transmembrane glycoprotein with a signal peptide, an extracellular region, a transmembrane region, and a cytoplasmic domain. IL2RA is expressed on activated T cells and regulatory T cells, and is capable of binding IL2 with low affinity by itself. However, a ligand-induced high affinity heterotrimeric receptor complex is produced when IL2RA is associated non-covelently with the IL2 receptor beta and gamma chain, and subsequently initiates the intacellular signal pathways such as MAPK or JAK/STAT. On dendritic cells (DC), CD25 has been previously regarded as an activation marker, while both murine and human DC can express CD25, they do not express the beta-chain of the IL-2 receptor, which is indispensable for the execution of IL-2 signaling. The IL2RA (CD25) gene is a substantial component of the high-affinity receptor molecule highly expressed by activated T lymphocytes. Recently, a strong evidence was obtained for the involvement of IL-2RA in conferring susceptibility to type 1 diabetes (T1D). Cancer growth and development is associated with the stimulation of the innate immune system, including enhanced interleukin 2 receptor (IL-2R) expression in immune cells and its shedding into the circulation in a soluble form of sIL-2Ralpha. In most haematological malignancies, including different types of leukaemias and lymphomas, sIL-2Ralpha has been found to be released directly from the surface of neoplastic cells thus reflecting the tumour bulk, turnover and activity. Several studies have proved that not only lymphoid cancer cells, but also some non-lymphoid cancer cells, express IL-2R on their surface. They include malignant melanoma and carcinomas of the kidney, head and neck, oesophagus and lung. Thus, sIL-2Ralpha is elevated in most proliferative disturbances of the hematopoietic system and in many solid tumors. |
Source : | Baculovirus-Insect Cells |
Species : | Rat |
Tag : | His |
Predicted N Terminal : | Glu 22 |
Form : | Lyophilized from sterile 20 mM Tris, 500 mM NaCl, pH 7.5, 10 % glycerol. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. |
Molecular Mass : | The recombinant rat Il2ra consists of 225 amino acids and predicts a molecular mass of 25.9 kDa. |
Protein length : | Met1-Gln235 |
Endotoxin : | < 1.0 EU per μg protein as determined by the LAL method. |
Purity : | > 95 % as determined by SDS-PAGE. |
Stability : | Samples are stable for up to twelve months from date of receipt at -70 centigrade. |
Storage : | Store it under sterile conditions at -20 centigrade to -80 centigrade. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles. |
Reconstitution : | It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 mg/ml. Centrifuge the vial at 4℃ before opening to recover the entire contents. |
Shipping : | In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise. |
Gene Name : | Il2ra interleukin 2 receptor, alpha [ Rattus norvegicus ] |
Official Symbol : | IL2RA |
Synonyms : | IL2RA; IL2-RA; IL-2-RA; IL-2R subunit alpha; IL2RAC; |
Gene ID : | 25704 |
mRNA Refseq : | NM_013163 |
Protein Refseq : | NP_037295 |
UniProt ID : | P26897 |
Products Types
◆ Recombinant Protein | ||
Il2ra-1677M | Recombinant Mouse Il2ra Protein, His-tagged | +Inquiry |
Il2ra-5704M | Active Recombinant Mouse Il2ra protein(Met1-Lys236), hFc-tagged | +Inquiry |
IL2RA-2698R | Recombinant Rat IL2RA Protein, His (Fc)-Avi-tagged | +Inquiry |
IL2RA-5198H | Recombinant Human IL2RA Protein | +Inquiry |
IL2RA-2068R | Recombinant Rhesus Macaque IL2RA Protein, His (Fc)-Avi-tagged | +Inquiry |
◆ Lysates | ||
IL2RA-1015CCL | Recombinant Cynomolgus IL2RA cell lysate | +Inquiry |
IL2RA-2907HCL | Recombinant Human IL2RA cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionThe combination of IL2RA and other drugs may produce nausea, vomiting, rash and other adverse reactions, should be monitored.
The frequency of use of IL2RA depends on the specific situation of the patient, and is generally used 1-3 times per week.
IL2RA, in the right dosage and frequency of use, can significantly relieve symptoms of diseases such as autoimmune diseases and organ transplant rejection.
Can assist in the treatment of some types of malignant tumors, but it is not a complete cure for cancer.
The effective rate of IL2RA therapy depends on many factors such as the type of disease, the patient's condition and the treatment regimen, and the effective rate is generally between 50% and 90%.
Indications of IL2RA include a variety of autoimmune diseases, organ transplant rejection and malignant tumors.
Customer Reviews (3)
Write a reviewSecurity is very high and can be used with confidence.
Structure is very stable and not prone to mutation.
The amount of expression is very high and can be easily detected.
Ask a Question for All IL2RA Products
Required fields are marked with *
My Review for All IL2RA Products
Required fields are marked with *
Inquiry Basket